Skip to content
DataLookout
Menu

NCT07370116

Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 30, 2026 to Mar 31, 2027 Show 8 more changesShow less
    • Phase changed: Phase 2 → Not applicable
    • Recruitment opened
    • Start date changed from estimate of Apr 1, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 16 words
    • Study completion pushed from Sep 2026 to Jun 30, 2027
    • Secondary endpoints: details revised at 1 of 9 entries
    • Site details revised
    • Collaborators revised (10)
  2. Notable Start date: Mar 1, 2026 to Apr 1, 2026
    • Primary completion date: Jun 30, 2026 to Jul 30, 2026
    • Study completion date: Aug 2026 to Sep 2026
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Comprehensive Complication Index
Timeframe: 30 days postoperatively

Secondary (9)

pancreaticoduodenectomy-specific complications
abdominal complications
pulmonary complications
comfort
Time to tolerate oral intake (liquids/solids)
Show 4 moreShow less
Hospitalization cost
Mortality rate
Rescue nasogastric tube insertion
Length of stay

Arms and interventions

routine nasogastric tubeActive comparator

standard nasogastric tube placement with the tube retained postoperatively

routine omission of the nasogastric tubeExperimental

avoidance of prophylactic nasogastric tube placement

Procedures: nasogastric tube decompression, Omission of nasogastric tube decompression

Sites

1 site in 1 country

  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China